SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Κύριος συγγραφέας: | Meem, Manila |
---|---|
Άλλοι συγγραφείς: | Akter, Dr. Raushanara |
Μορφή: | Thesis |
Γλώσσα: | English |
Έκδοση: |
Brac University
2023
|
Θέματα: | |
Διαθέσιμο Online: | http://hdl.handle.net/10361/18081 |
Παρόμοια τεκμήρια
-
A review on potential of PARP inhibitors in the treatment of prostate cancer
ανά: Islam, Saidul
Έκδοση: (2022) -
RIPK pathway, as a potential target, for cancer treatment - a review
ανά: Jahan, Nusrat
Έκδοση: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
ανά: Flora, Sanzida Alam
Έκδοση: (2024) -
Immunotherapy in the Management of Lung Cancer
ανά: Tasnim, Humayra
Έκδοση: (2022) -
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
ανά: Ratu, Tabassum
Έκδοση: (2024)